Our study now shows more cancer cells with hyperactivity in NF-kB signaling after CYLD knockout (11% in the control group, 18% in the knockout group, p-Value < 2.2×10−6; Figure 5A) in the single-cell RNA sequencing analysis of the two groups of mouse xenografts. This evidence concerns the gene NFKB1 and cancer.